Features Pricing Learn Reverse Splits Tracker Shelf & ATM Tracker Warrant Tracker PIPE Deal Tracker Weekly Report FAQ API Sign In →
65 /100
HIGH RISK
Score updated Oct 13, 2026

ARQT — Arcutis Biotherapeutics, Inc. Dilution Risk Tracker

Track ARQT dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track ARQT — Get alerts when the score changes →

As of October 13, 2026, Arcutis Biotherapeutics, Inc. (ARQT) has a DilutionWatch DilutionScore of 65/100, rated HIGH dilution risk. Arcutis Biotherapeutics, Inc. has a market capitalization of $3.30B, 125.69M shares outstanding, 272 institutional holders tracked.

This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.

Score Breakdown

📋 Offering Ability
22
💰 Cash Runway
95
📊 Float Risk
30
⚠️ Warrant Exposure
15
🔄 Convertible Debt
15

Dilution Forecast

🌥️
Advisory
Moderate dilution signals present
model est. 30%
💰 Capital Raise model 55%
• Critical: only 2.9 months cash remaining
📉 Score Deterioration model 10%
• Score in HIGH risk zone (65/100)
🔔 Track ARQT — Get forecast alerts →

Market Data

Market Cap$3.30B
Shares Outstanding125.69M
Float92.59M
Cash$34.12M
Debt$108.90M
Short InterestN/A

Source-Backed Evidence Depth

This public preview uses stored DilutionWatch fields and linked SEC/market records only. Missing values are not estimated.

FieldCurrent ValueBasis
DilutionScore65/100DilutionWatch score record
Shares Outstanding125.69MVerified float table or market cache
Public Float92.59MVerified float table or market cache
Market Cap$3.30BMarket data cache
Cash Runway2.9 monthsDilutionWatch score inputs
Shelf CapacityNone in current score inputsSEC-derived dilution fields
ATM CapacityNone in current score inputsSEC-derived dilution fields
Outstanding WarrantsNone in current score inputsSEC-derived dilution fields

Recent source-backed SEC insight records available on this page: 6.

Recent SEC source mix: 4 5, XBRL 1.

The page does not infer future share issuance, financing probability, cash needs, management intent, or price impact when source fields are absent.

Institutional Holdings

QoQ: ↑ 18.6% shares (2026Q1 vs prior)
272 institutional holders · 156.41M shares
#1 MORGAN STANLEY 12.84M shares
#2 SUVRETTA CAPITAL MANAGEMENT, LLC 12.33M shares
#3 Frazier Life Sciences Management, L.P. 9.87M shares
+ 17 more holders Sign up free to view →

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest21.69M
Days to Cover4.8
% of Float23.4%
FINRA data as of Sep 30, 2026

Recent SEC Activity

xbrl XBRL CONVERTIBLE 2023-02-28
4 INSIDER TRANSACTION 2026-04-03
4 INSIDER TRANSACTION 2026-03-04
4 INSIDER TRANSACTION 2026-03-04
4 INSIDER TRANSACTION 2026-03-03
Full SEC filing analysis available with free account →

Recent News

No recent news available for this ticker.

Factual ARQT Dilution Snapshot

Arcutis Biotherapeutics, Inc. (ARQT) has a DilutionScore of 65/100, rated High dilution risk. Score date: October 13, 2026.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.

DilutionScore History — Last 90 Days

ARQT's DilutionScore is currently 65/100 (High risk), with 1 score change tracked over 89 days. The score improved from 50/100 (Medium risk).

Period Score Risk Level Duration
Aug 22 – Oct 13, 202665/100HIGH53 days
Jul 16 – Aug 21, 202650/100MEDIUM36 days

Score recalculated daily from SEC filings and market data. Sign up free for real-time score change alerts.

Share Dilution History

ARQT shares outstanding have increased 0.8% from 124.03M (Mar 2026) to 125.08M (May 2026). Each increase represents potential dilution to existing shareholders.

Date Shares Outstanding Public Float Change
May 23, 2026125.08M92.59M▲ 0.05%
May 18, 2026125.08M92.54M▼ 0.46%
May 09, 2026125.08M92.96M▲ 0.85%
May 01, 2026125.07M92.18M▲ 0.29%
Apr 15, 2026124.03M91.91M▲ 0.01%
Mar 17, 2026124.03M91.90M▼ 0.07%

Share counts sourced from verified regulatory filings. Increases indicate dilution events.

Track ARQT Dilution Risk in Real-Time
DilutionWatch monitors SEC filings 24/7 and alerts you the moment ARQT files a shelf registration, ATM offering, warrant notice, or convertible note. Free tier available — no credit card required.
Start Tracking ARQT — Free
Email alert within minutes of any SEC filing Daily DilutionScore™ recalculation Score history & trend tracking Tracks 8,000+ tickers simultaneously

Related Stocks — HIGH Risk

Other HIGH dilution risk stocks tracked by DilutionWatch with similar profiles:

→ Biotech / Pharma sector dilution risk overview

Browse all 8,490+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
More Research for ARQT
ARQT FDA Catalyst Timeline & Biotech Grade — BiotechSigns

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.